Preconceptual Folic Acid Use and Recurrence Risk Counseling for Congenital Heart Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1747-0803|10|3|219-225

ISSN： 1747-079x

Source： CONGENITAL HEART DISEASE, Vol.10, Iss.3, 2015-05, pp. : 219-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Periconceptional Folic Acid Supplementation and Infant Risk of Congenital Heart Defects in Norway 1999–2009

By  

PAEDIATRIC & PERINATAL EPIDEMIOLOGY, Vol. 29, Iss. 5, 2015-09 ,pp. : 391-400

John Wiley & Sons Inc

Access to resources Recommend Favorite

Annual Trends in Use of Periconceptional Folic Acid and Birth Prevalence of Major Congenital Malformations

By  

Current Drug Safety, Vol. 8, Iss. 3, 2013-01 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

Congenital heart disease and pregnancy

By Wallis Helen   Thorne Sara  

Women's Health, Vol. 2, Iss. 5, 2006-09 ,pp. : 743-752

Future Medicine

Access to resources Recommend Favorite

Antitachycardia Pacemakers in Congenital Heart Disease

By  

CONGENITAL HEART DISEASE, Vol. 10, Iss. 2, 2015-03 ,pp. : 180-184

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Folic Acid-Fortified Milk in the Elderly Population

By  

Gerontology, Vol. 44, Iss. 6, 1998-11 ,pp. : 336-339

Karger

Access to resources Recommend Favorite